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1. Introduction 
Like with many other enzymes, also in the case of 
cathepsins - the intracellular proteinases - the 
existence of isozymes has been observed. Press et al. 
[l] reported at least 10 different forms of cathepsin D 
observed on ion-exchange chromatography; they all 
showed the same enzymatic specificity when assayed 
with the B-chain of oxidized insulin as substrate. Using 
isoelectric focusing, Barrett [2] has been able to 
obtain three isozymes of cathepsin D with isoelectric 
points of 5.7, 6.0, and 6.5. Otto [3] has described 
the isolation of two cathepsins, BI and B,, from 
bovine spleen. The two enzymes differ in molecular 
weight and in specificity when assayed with low mole- 
cular weight substrates. Cathepsin B, occurs in several 
forms, as follows from our own preceding experiments 
[4, 51 and also from the data of Franklin and Metrione 
[6]. The latter authors have obtained 4 to 5 forms of 
cathepsin BI by ion-exchange chromatography. All 
these forms showed the same molecular weight, the 
same N-terminal amino acid, and were susceptible to 
the same activators and the same inhibitors. The 
authors, however, did not investigate the enzymatic 
specificity of the individual forms. 
In this paper we describe the modification of our 
earlier isolation procedure, the preparation of four 
forms of cathepsin B I, their final purification by 
affinity chromatography on a gel with covalently 
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bound mercury, the determination of their N-terminal 
amino acids, and the comparison of the specificities 
of these isozymes assayed with the B-chain of oxidized 
insulin as substrate. 
2. Material and methods 
A homogenate of fresh bovine spleen served as 
starting material for the preparation of cathepsin BI. 
The extraction and precipitation with ammonium 
sulfate has been carried out according to Otto [3]. 
2.1. Gel filtration on Sephadex G-1.50 
The precipitate obtained at 46-56% saturation 
with ammonium sulfate was dialyzed against water, 
concentrated by ultrafiltration, and separated by gel 
filtration on a column of Sephadex G-l 50 (Pharmacia 
Uppsala) in 0.01 M phosphate buffer at pH 6.9. The 
elution volumes of human serum albumin, egg albumin, 
and bovine ribonuclease were determined on the 
same column under identical conditions of the 
experiment. 
2.2. Chromatography on DEAE-Sephadex A-50 
The effluent from the above described column, 
corresponding with respect to its elution volume to a 
product of molecular weight of 24,000-25,000 and 
showing enzymatic activity when assayed with BAPN 
as substrate, was fractionated further by chromato- 
graphy on a column of DEAE-Sephadex A-50 
(Pharmacia, Uppsala), equilibrated in 0.01 M phos- 
phate at pH 6.9. The proteins were eluted from the 
column by a stepwise gradient of NaCl(O.1 M and 
0.2 M) in the same buffer. 
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2.3. Affinity chromatography I I 
To Sepharose 4B (Pharmacia, Uppsala) activated 
with cyanogen bromide [7] 1-aminophenylmercuric 
acetate (a product of Aldrich) was bound according 
to Sluyterman and Wijdenes [S]. The affinity chroma- 
tography of cathepsin B, was carried out under con- 
ditions analogous to those used by these authors for 
papain. 
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2.4. Assay of proteolytic activity 
To 50 pl of cathepsin B, solution, 1.5 ml of 0.1 M 
phosphate buffer at pH 6.0, 1 mM in EDTA and 
25 mM in cysteine was added and the sample was 
activated 5 min at 40’. A solution (50 ~1) of BAPN 
in dimethylformamide (40 mg/ml) was added to the 
activated sample. After 10-l 5 min of incubation at 
40” the digestion was discontinued by the addition of 
100 ~1 of glacial acetic acid. The p-nitroaniline 
liberated was determined photometrically at 405 nm. 
One unit we consider the quantity of cathepsin B, 
which under the described conditions will raise the 
absorbance by 0.1 in 1 min. 
0.6 
2.5. Digestion of B-chain of oxidized insulin 
The B-chain (300 pg) of oxidized insulin was 
digested by 2 cathepsin B, units in 500 ~1 of 0.05 M 
pyridine acetate buffer at pH 6.0, 1 mM in EDTA and 
5 mM in dithiothreitol, 17 hr at 39”. The digest was 
taken to dryness. The digest was taken to dryness. The 
specificity of the cleavage was examined by the 
method of peptide maps. The digest was separated on 
Whatman No. 3MM paper. High-voltage electrophoresis 
at pH 1.9 in the mixture acetic acid-formic acid- 
water (15: 5: 80, v/v) was used for the first direction 
and chromatography in the system butanol:acetic 
acid:pyridine:water (15:3: 10: 12, by vol) for the 
second direction. The technique of small 20 X 20 cm 
maps, prepared under analogous conditions, was used 
for routine analyses. The peptides were detected on 
the paper by 0.2% solution of ninhydrin in acetone. 
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Fig. 1. a) Chromatography on DEAE-Sephadex A-SO. 1200 ml 
of the Sephadex G-150 fraction active toward BAPN was 
charged on a DEAE-Sephadex A-50 column (4 X 17 cm): the 
colum was eluted by 0.01 M phosphate buffer at pH 6.9, 
0.1 M NaCl in the same buffer (J) and 0.2 M NaCl in the 
same buffer (f), fractions 26 ml/30 min. (-) Absorbance at 
280 nm; (- - - -) activity toward BAPN-(absorbance at 
405 nm). b) Rechromatography on DEAE Sephadex A-50 of 
combined peaks no. I and II from the column presented in 
a. See a for experimental conditions. c) Rechromatography 
on DEAE-Sephadex A-SO of peak IV from the column 
presented in a. See a for experimental conditions 
2.6. N-terminal end-group analysis 
2.7. Disc electrophoresis 
Disc electrophoresis in 15% polyacrylamide gel was 
carried out in Tris-glycine buffer at pH 8.3 according 
to Davis [ 1 I]. 
The N-terminal amino acids were determined by a 
modification [9] of the Dansyl technique. The 
Dansyl-amino acids were identified by chromatography 
on 5 X 5 cm polyamide layer sheets, using the modifi- 
cation described by Hartley [lo]. 
3. Results and discussion 
The starting material used for the preparation of 
cathepsin B, in our earlier studies [4] was the acetone 
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Fig. 2. Affinity chromatography of cathepsin Br on Sepharose 
mercurial column. Purification of 100 units of cathepsin 
B i -IV on a Sepharose 4B mercurial column (1.6 X 12 cm), 
fractions 2 ml/min. 1 Addition of HgC12 to the standard 
buffer. 
powder of bovine spleen; this material was fractionated 
by precipitation with ammonium sulfate, then sub- 
jected to chromatography on CM-Sephadex, DEAE- 
Sephadex, and gel filtration on Sephadex G-100. In 
this study we have modified this procedure: we have 
started with a homogenate of fresh bovine spleen and 
used fractionation on Sephadex G-l 50 as another 
purification step following the precipitation with 
ammonium sulfate. This operation has enabled us a 
very good resolution of cathepsin C, D, and BI [ 121; 
cathepsin B I is equilibrated by this operation in a solu- 
tion suitable for the subsequent chromatographic frac- 
tionation on DEAE-Sephadex. When we fractionated 
cathepsin B I from bovine spleen on DEAE-Sephadex 
in our earlier isolation experiments, we always observed 
several protein peaks showing enzymatic activity when 
assayed with BAPN as substrate. Of these peaks we 
employed only the most acidic form of cathepsin B, 
since it showed the relatively highest homogeneity. 
Cathepsin B,, which hydrolyzes BAPN, emerges 
from the DEAE-Sephadex A-50 column under the 
conditions of ion-exchange chromatography described 
in the experimental part at least in four fractions 
(fig. la). The first three forms are eluted by 0.1 M 
NaCl, the fourth form is displaced by 0.2 M NaCl. 
The occurrence of enzymes in several forms leads 
us always to the question as to whether we are not 
dealing with artifacts formed during the isolation 
process. In an effort to verify that the individual 
active forms are not artifacts and that their elution 
volume on chromatography is reproducible, we 
rechromatographed combined forms I and II (fig. lb) 
and form IV (fig. lc) under identical conditions. A 
comparison of fig. la, b, and c shows the complete 
reproducibility of the positions of peaks active 
toward BAPN as substrate. We wish to stress that we 
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Fig. 3. Peptide maps of B-chain of oxidized insulin digested by cathepsin Br-I and Br-IV, see text for further details; + = application 
of the digest, A = reference mixture of amino acids, D = di(2,4dinitrophenyl-)ethylenediamine as marker. 
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have observed analogous enzyme components during 
our repeated isolation experiments with cathepsin B, 
in the past few years, even in cases where entirely 
different conditions of isolation were used (such as, 
e.g. when the acetone powder of spleen was used or 
when the fractionation with ammonium sulfate was 
replaced by fractionation with acetone). It is also 
important that similar results were obtained also in 
other laboratories [6]. 
The examination of forms I through IV by disc 
electrophoresis howed their inhomogeneity. We used 
therefore affinity chromatography on a column of 
Sepharose 4B with covalently bound mercury and 
were able to achieve a two- to three-fold purification 
of all fractions of cathepsin B 1 which is an SH-enzyme. 
Cathepsins B, are bound by the SH-group of their 
active site to the Hg-modified carrier whereas proteins 
lacking free SH-groups are not retarded in the column 
and are eluted by the starting buffer. Active cathepsin 
Bl is displaced from the column by 0.5 mM HgCl2 
(fig. 2). This operation will not only separate exogenous 
proteins contaminating cathepsin BI but at the same 
time also that part of cathepsin BI which no longer 
can be activated. Another advantage of this operation 
is that the unstable SH-enzyme is converted into its 
Hg-form which, in analogy to papain, is more stable 
than the SH-form. From the practical viewpoint we 
find that it is better to use affinity chromatography 
at the final stage of the purification process or at least 
after other high molecular weight proteins with a free 
SH-group (such as, e.g. cathepsin C), which consider- 
ably decrease the capacity of the carrier for cathepsin 
B,, have been removed. 
We have determined the N-terminal end groups of 
all the forms isolated by the sensitive Dansyl-technique. 
Leucine has been shown unambiguously to be the 
N-terminal amino acid of all four forms. At this in- 
stance we wish to correct our earlier information [4] 
on cathepsin BI-IV reporting isoleucine and valine as 
its N-terminal amino acids. The N-terminal amino acids 
were originally examined by the phenylthiohydantoin 
technique and the results were misinterpreted because 
of incomplete separation of ETH-leucine and PTH- 
isoleucine. Valine was obviously derived from a con- 
taminating, enzymatically inactive protein. 
To illustrate the specificity of the forms, fig. 3 
shows schematically peptide maps of the B-chain of 
oxidized insulin digested by cathepsins B-l and B-IV, 
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i.e. by the forms which differ most on chromatography 
on DEAE-Sephadex. There is no essential difference 
in the maps of digests prepared with cathepsins B ,-I 
and Bl-IV and with the remaining cathepsins, BI-II 
and BI-III. This leads us to postulate that the specificity 
of all four forms toward this substrate is essentially the 
same. 
The results presented above, especially the finding 
that the individual forms of cathepsin B 1, isolated 
from the same tissue by different procedures, show 
the same N-terminal amino acid, the same specificity 
when examined with the B-chain of oxidized insulin, 
and the same molecular weight yet differ in elution 
volumes on ion-exchange chromatography, permit us 
to define [ 131 these forms of the enzyme as the iso- 
enzymes of cathepsin B I. 
It remains to be shown whether the same isozymes 
can be obtained also from other tissues or from tissues 
of organisms at pathological states. 
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